Jump to main content
Jump to site search

Issue 1, 2015
Previous Article Next Article

The status of the lysophosphatidic acid receptor type 1 (LPA1R)

Author affiliations


Lysophospholipids are lipid molecules that are receiving growing attention because, in addition to their structural function in the cell membrane, they are now regarded as important regulators for diverse biological functions through activation of specific receptors. These receptors have been characterized during the last two decades as G protein-coupled receptors (GPCRs) and, among them, two families stand out: lysophosphatidic acid (LPA1–6) and sphingosine 1-phoshate (S1P1–5) receptors. Despite their interest, the high structural similarity between them has restrained the development of selective and high affinity ligands and therefore the elucidation of the role of these receptors in the central nervous system (CNS). This review provides an overview about the different LPA receptors with a special focus on the LPA1 subtype from a medicinal chemistry perspective. It summarizes the most recent developments in the search for selective and specific agonists and antagonists of the LPA1 receptor and highlights their current status in the drug development pipeline.

Graphical abstract: The status of the lysophosphatidic acid receptor type 1 (LPA1R)

Back to tab navigation

Publication details

The article was received on 01 Aug 2014, accepted on 22 Sep 2014 and first published on 22 Sep 2014

Article type: Review Article
DOI: 10.1039/C4MD00333K
Author version
Download author version (PDF)
Med. Chem. Commun., 2015,6, 13-23

  •   Request permissions

    The status of the lysophosphatidic acid receptor type 1 (LPA1R)

    I. González-Gil, D. Zian, H. Vázquez-Villa, S. Ortega-Gutiérrez and M. L. López-Rodríguez, Med. Chem. Commun., 2015, 6, 13
    DOI: 10.1039/C4MD00333K

Search articles by author